Effect of Subcision and Suction on Acne Scars

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Murad Alam, Northwestern University

ClinicalTrials.gov Identifier:

NCT01696513

First received: September 14, 2012

Last updated: March 13, 2017

Last verified: March 2017

History of Changes

Purpose

The primary objective of this study is to determine whether the use of standard treatment in conjunction with suction will improve acne scars compared to a standard treatment alone.

Condition	Intervention
Acne Scars	Procedure: Suction Procedure: Subcision


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Outcomes Assessor) Primary Purpose: Treatment
Official Title:	Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars

Resource links provided by NLM:

MedlinePlus related topics: Acne Scars

U.S. FDA Resources

Further study details as provided by Murad Alam, Northwestern University:

Primary Outcome Measures:

Change in acne scarring compared to baseline after treatments [ Time Frame: Baseline and 4 months ]
The change in acne scarring is measured using a global scarring grading system to compare baseline scarring to the treatments.


Estimated Enrollment:	20
Study Start Date:	September 2012
Estimated Study Completion Date:	August 2017
Estimated Primary Completion Date:	August 2017 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Subcision & Suction Standard treatment for acne scars followed by suction.	Procedure: Suction Procedure: Subcision
Active Comparator: Subcision Standard treatment for acne scars only	Procedure: Subcision

Eligibility


Ages Eligible for Study:	18 Years to 65 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Age 18 and over
Have bilateral rolling acne scars
Are in good health
Subject has the willingness and ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Exclusion Criteria:

Under 18 years of age
Pregnancy or lactation
Unable to understand the protocol or give informed consent
Has mental illness
Recent Accutane use in the past 6 months
Prone to hypertrophic and keloidal scarring

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01696513

Locations


United States, Illinois
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States, 60611

Sponsors and Collaborators

Northwestern University

Investigators


Principal Investigator:	Murad Alam, MD	Northwestern University

More Information


Responsible Party:	Murad Alam, Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation, Northwestern University
ClinicalTrials.gov Identifier:	NCT01696513 History of Changes
Other Study ID Numbers:	STU66710
Study First Received:	September 14, 2012
Last Updated:	March 13, 2017

ClinicalTrials.gov processed this record on August 18, 2017

To Top